133 related articles for article (PubMed ID: 38060036)
21. Oncostatin M pathway plays a major role in the renal acute phase response.
Luyckx VA; Cairo LV; Compston CA; Phan WL; Mueller TF
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F875-83. PubMed ID: 19158344
[TBL] [Abstract][Full Text] [Related]
22. Morgellons: contested illness, diagnostic compromise and medicalisation.
Fair B
Sociol Health Illn; 2010 May; 32(4):597-612. PubMed ID: 20149149
[TBL] [Abstract][Full Text] [Related]
23. Increased serum human β-defensin-2 levels in atopic dermatitis: relationship to IL-22 and oncostatin M.
Kanda N; Watanabe S
Immunobiology; 2012 Apr; 217(4):436-45. PubMed ID: 22137028
[TBL] [Abstract][Full Text] [Related]
24. Dabigatran etexilate retards the initiation and progression of atherosclerotic lesions and inhibits the expression of oncostatin M in apolipoprotein E-deficient mice.
Preusch MR; Ieronimakis N; Wijelath ES; Cabbage S; Ricks J; Bea F; Reyes M; van Ryn J; Rosenfeld ME
Drug Des Devel Ther; 2015; 9():5203-11. PubMed ID: 26392754
[TBL] [Abstract][Full Text] [Related]
25. Decreased serum LL-37 and vitamin D3 levels in atopic dermatitis: relationship between IL-31 and oncostatin M.
Kanda N; Hau CS; Tada Y; Sato S; Watanabe S
Allergy; 2012 Jun; 67(6):804-12. PubMed ID: 22486751
[TBL] [Abstract][Full Text] [Related]
26. Hypnosis in the treatment of Morgellons disease: a case study.
Gartner AM; Dolan SL; Stanford MS; Elkins GR
Int J Clin Exp Hypn; 2011 Apr; 59(2):242-9. PubMed ID: 21390982
[TBL] [Abstract][Full Text] [Related]
27. Helicobacter pylori induces expression and secretion of oncostatin M in macrophages in vitro.
Zeaiter Z; Diaz H; Stein M; Huynh HQ
Dig Dis Sci; 2011 Mar; 56(3):689-97. PubMed ID: 20661773
[TBL] [Abstract][Full Text] [Related]
28. Delusional infestation with unusual pathogens: a report of three cases.
Dewan P; Miller J; Musters C; Taylor RE; Bewley AP
Clin Exp Dermatol; 2011 Oct; 36(7):745-8. PubMed ID: 21933231
[TBL] [Abstract][Full Text] [Related]
29. Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation.
Boniface K; Diveu C; Morel F; Pedretti N; Froger J; Ravon E; Garcia M; Venereau E; Preisser L; Guignouard E; Guillet G; Dagregorio G; Pène J; Moles JP; Yssel H; Chevalier S; Bernard FX; Gascan H; Lecron JC
J Immunol; 2007 Apr; 178(7):4615-22. PubMed ID: 17372020
[TBL] [Abstract][Full Text] [Related]
30. Oncostatin M, an Underestimated Player in the Central Nervous System.
Houben E; Hellings N; Broux B
Front Immunol; 2019; 10():1165. PubMed ID: 31191538
[TBL] [Abstract][Full Text] [Related]
31. Oncostatin M suppresses
Suehiro M; Numata T; Saito R; Yanagida N; Ishikawa C; Uchida K; Kawaguchi T; Yanase Y; Ishiuji Y; McGrath J; Tanaka A
Front Immunol; 2023; 14():1251031. PubMed ID: 38035099
[TBL] [Abstract][Full Text] [Related]
32. Morgellons disease, or antipsychotic-responsive delusional parasitosis, in an HIV patient: beliefs in the age of the Internet.
Freudenreich O; Kontos N; Tranulis C; Cather C
Psychosomatics; 2010; 51(6):453-7. PubMed ID: 21051675
[No Abstract] [Full Text] [Related]
33. Interleukin-6 cytokine family member oncostatin M is a hair-follicle-expressed factor with hair growth inhibitory properties.
Yu M; Kissling S; Freyschmidt-Paul P; Hoffmann R; Shapiro J; McElwee KJ
Exp Dermatol; 2008 Jan; 17(1):12-9. PubMed ID: 17979974
[TBL] [Abstract][Full Text] [Related]
34. OSMRβ mutants enhance basal keratinocyte differentiation via inactivation of the STAT5/KLF7 axis in PLCA patients.
Liu J; Chen J; Zhong Y; Yu X; Lu P; Feng J; Zhang X; Ma S; Yang C; Yang B; Rong Z
Protein Cell; 2021 Aug; 12(8):653-661. PubMed ID: 33502684
[No Abstract] [Full Text] [Related]
35. Oncostatin-M is an autocrine growth factor in Kaposi's sarcoma.
Cai J; Gill PS; Masood R; Chandrasoma P; Jung B; Law RE; Radka SF
Am J Pathol; 1994 Jul; 145(1):74-9. PubMed ID: 8030759
[TBL] [Abstract][Full Text] [Related]
36. An oral ulceration associated with Morgellons disease: a case report.
Grosskopf C; Desai B; Stoopler ET
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Aug; 112(2):e19-23. PubMed ID: 21749875
[TBL] [Abstract][Full Text] [Related]
37. Is Morgellons an organic disease? structural and functional abnormalities implicated in the pathophysiology of delusional infestation.
Chan S; Xiao A; Patel S; Nakamura M; Koo J
Dermatol Online J; 2020 Nov; 26(11):. PubMed ID: 33342168
[TBL] [Abstract][Full Text] [Related]
38. Oncostatin M as a new diagnostic, prognostic and therapeutic target in inflammatory bowel disease (IBD).
Verstockt S; Verstockt B; Vermeire S
Expert Opin Ther Targets; 2019 Nov; 23(11):943-954. PubMed ID: 31587593
[No Abstract] [Full Text] [Related]
39. Oncostatin M mediates STAT3-dependent intestinal epithelial restitution via increased cell proliferation, decreased apoptosis and upregulation of SERPIN family members.
Beigel F; Friedrich M; Probst C; Sotlar K; Göke B; Diegelmann J; Brand S
PLoS One; 2014; 9(4):e93498. PubMed ID: 24710357
[TBL] [Abstract][Full Text] [Related]
40. The upregulation of oncostatin M in inflamed human dental pulps.
Huang FM; Tsai CH; Yang SF; Chang YC
Int Endod J; 2009 Jul; 42(7):627-31. PubMed ID: 19467046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
